Home/Publication/ChrysCapital to Take Control of Novartis India
ChrysCapital to Take Control of Novartis India 

23 Feb 2026

US$ 20.00

ChrysCapital has agreed to acquire a 70.7% stake in the listed Novartis India Ltd (NIL) from the Switzerland-based...

Price / article: US$20.00
OR existing subscriber
Related Publications

Peak XV Partners has raised US$1.3 bn which includes funds that focus on Indian companies at seed and venture stages ......

Granite Asia Partners (Granite) has closed an IPO fund that focuses on artificial intelligence (AI), at US$110 m ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.